← Back to Search

Diagnostic Test

Swab for Respiratory Syncytial Virus (INSPIRE Trial)

N/A
Recruiting
Led By Robert Rosen
Research Sponsored by LumiraDx UK Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

INSPIRE Trial Summary

This trial looked at how well the LumiraDx test works for Influenza A/B and RSV at various point of care testing sites.

Eligible Conditions
  • Respiratory Syncytial Virus
  • Flu

INSPIRE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance evaluation by health care professionals
Performance evaluation by non-laboratory users

INSPIRE Trial Design

2Treatment groups
Experimental Treatment
Group I: Nasopharyngeal swabExperimental Treatment1 Intervention
Nasopharyngeal swab from subjects with signs and symptoms of influenza and/or RSV-like illness
Group II: Nasal swabExperimental Treatment1 Intervention
Nasal swab from subjects with signs and symptoms of influenza and/or RSV-like illness
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Swab
2019
N/A
~100

Find a Location

Who is running the clinical trial?

LumiraDx UK LimitedLead Sponsor
15 Previous Clinical Trials
32,490 Total Patients Enrolled
Robert RosenPrincipal InvestigatorArdmore Family Practice
1 Previous Clinical Trials
1,134 Total Patients Enrolled
Andre GvozdenPrincipal InvestigatorGvozden Pediatrics
1 Previous Clinical Trials
1,134 Total Patients Enrolled

Media Library

Swab (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT04288921 — N/A
Respiratory Syncytial Virus Research Study Groups: Nasopharyngeal swab, Nasal swab
Respiratory Syncytial Virus Clinical Trial 2023: Swab Highlights & Side Effects. Trial Name: NCT04288921 — N/A
Swab (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04288921 — N/A
~381 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top